Clinical Trial Update: Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing levonadifloxacin (IV and oral) to linezolid (IV and oral) for acute bacterial skin and skin structure infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Levonadifloxacin (levonadifloxacin)
• Linezolid (Linezolid)

Snippet

Sponsor: Wockhardt | Conditions: Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Status: COMPLETED